Monoclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

• Product Name Alternative:

  P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1

• Synonyms:

  Cyclin Dependent Kinase Inhibitor 2A

• Host:

  Mouse

• Immunogen:

  RPA794Hu01-Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

• Isotype:

  IgG

• Source:

  Monoclonal antibody preparation

• Applications:

  WB; IHC; ICC; IP.

• Field of Research:

  Tumor immunity, Developmental science

• Buffer:

  PBS, pH7.4, containing 0.02% NaN3,50% glycerol.

• Recommended Usage:

  Western blotting: 0.5-2µg/mL;
  Immunohistochemistry: 5-20µg/mL;
  Immunocytochemistry: 5-20µg/mL;
  Optimal working dilutions must be determined by end user.

• Organism Species:

  Homo sapiens (Human)